Loading clinical trials...
Loading clinical trials...
The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.
In Step I, concept elicitation one-on-one interviews (via telephone or in person) will be conducted. The aims of the concept elicitation interviews are to: 1. Identify the most common symptoms, as well as the most important symptoms, for patients with PSC, and 2. Assess whether these symptoms impact day-to-day functioning An instrument will be developed based on the symptoms reported and in Step II of the study, the performance of the instrument will be assessed with further interviews.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
University of Colorado Hospital, Denver Health Medical Center
Aurora, Colorado, United States
University of Miami Miller School of Medicine - Schiff Center for Liver Diseases
Miami, Florida, United States
Evidera
Bethesda, Maryland, United States
Duke University Medical Center
Durham, North Carolina, United States
Organ Care Research Swedish Medical Center
Seattle, Washington, United States
Start Date
October 1, 2014
Primary Completion Date
October 1, 2015
Completion Date
October 1, 2015
Last Updated
February 9, 2016
26
ACTUAL participants
Lead Sponsor
Gilead Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02137668